{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T18:18:26Z","timestamp":1760897906571,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T00:00:00Z","timestamp":1670630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Surgery"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.asjsur.2022.12.014","type":"journal-article","created":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T15:00:32Z","timestamp":1671289232000},"page":"4357-4362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prognostic factors for primary diffuse large B-cell lymphoma of the brain"],"prefix":"10.1016","volume":"46","author":[{"given":"Zhuoya","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3297-9183","authenticated-orcid":false,"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.asjsur.2022.12.014_bib1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1182\/blood-2006-11-051672","article-title":"Proposed classification of lymphoid neoplasms for epidemiologic research from the pathology working group of the international lymphoma Epidemiology consortium (InterLymph)","volume":"110","author":"Morton","year":"2007","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.asjsur.2022.12.014_bib2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1023\/A:1008282818705","article-title":"Primary extranodal non-Hodgkin's lymphomas. Part 1: gastrointestinal, cutaneous and genitourinary lymphomas","volume":"8","author":"Zucca","year":"1997","journal-title":"Ann Oncol : official journal of the European Society for Medical Oncology"},{"issue":"22","key":"10.1016\/j.asjsur.2022.12.014_bib3","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1200\/JCO.2005.09.137","article-title":"Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia","volume":"23","author":"Sehn","year":"2005","journal-title":"J\u00a0Clin Oncol : official journal of the American Society of Clinical Oncology"},{"issue":"2","key":"10.1016\/j.asjsur.2022.12.014_bib4","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/bjh.15444","article-title":"Stage I Non-Hodgkin Lymphoma: difference in survival outcome by primary extranodal site of involvement","volume":"185","author":"Chihara","year":"2019","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.asjsur.2022.12.014_bib5","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/ajh.23638","article-title":"Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database","volume":"89","author":"Castillo","year":"2014","journal-title":"American j hematol"},{"issue":"4","key":"10.1016\/j.asjsur.2022.12.014_bib6","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3174\/ajnr.A1447","article-title":"CT and MR imaging features of primary central nervous system lymphoma in Norway, 1989-2003","volume":"30","author":"Haldorsen","year":"2009","journal-title":"AJNR American J. neuroradiol."},{"issue":"9","key":"10.1016\/j.asjsur.2022.12.014_bib7","doi-asserted-by":"crossref","first-page":"498","DOI":"10.5348\/ijcri-2013-09-365-CR-9","article-title":"Primary cerebellar B cell lymphoma: a case report","volume":"4","author":"Datta","year":"2014","journal-title":"Int J Case Rep Images"},{"issue":"3","key":"10.1016\/j.asjsur.2022.12.014_bib8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/bjh.14073","article-title":"Trends in primary central nervous system lymphoma incidence and survival in the U.S","volume":"174","author":"Shiels","year":"2016","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.asjsur.2022.12.014_bib9","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/gerona\/glw240","article-title":"Chronic inflammation: accelerator of biological aging","volume":"72","author":"Foug\u00e8re","year":"2017","journal-title":"J\u00a0Gerontol Biol Med Sci"},{"issue":"8","key":"10.1016\/j.asjsur.2022.12.014_bib10","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0531-5565(03)00090-1","article-title":"Immunosenescence, autoimmunity, and rheumatoid arthritis","volume":"38","author":"Weyand","year":"2003","journal-title":"Exp gerontol"},{"issue":"25","key":"10.1016\/j.asjsur.2022.12.014_bib11","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"10.1016\/j.asjsur.2022.12.014_bib12","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1002\/cncr.30965","article-title":"Diagnosis and management of primary central nervous system lymphoma","volume":"123","author":"Han","year":"2017","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.asjsur.2022.12.014_bib13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1023\/A:1008201717089","article-title":"Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: results of a critical review of the literature","volume":"8","author":"Reni","year":"1997","journal-title":"Ann Oncol : official journal of the European Society for Medical Oncology"},{"issue":"2","key":"10.1016\/j.asjsur.2022.12.014_bib14","first-page":"261","article-title":"Primary intracerebral malignant lymphoma: report of 248 cases","volume":"92","author":"Bataille","year":"2000","journal-title":"J\u00a0neurosurg"},{"issue":"1","key":"10.1016\/j.asjsur.2022.12.014_bib15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejso.2004.10.002","article-title":"Surgical removal of primary central nervous system lymphomas (PCNSL) presenting as space occupying lesions: a series of 33 cases","volume":"31","author":"Bellinzona","year":"2005","journal-title":"European J surgical oncol: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology"},{"issue":"12","key":"10.1016\/j.asjsur.2022.12.014_bib16","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/neuonc\/nos159","article-title":"Surgery for primary CNS lymphoma? Challenging a paradigm","volume":"14","author":"Weller","year":"2012","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.asjsur.2022.12.014_bib17","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3109\/02688697.2015.1071328","article-title":"The possible benefit from total tumour resection in primary diffuse large B-cell lymphoma of central nervous system - a one-decade single-centre experience","volume":"30","author":"Jelicic","year":"2016","journal-title":"Br J Neurosurg"},{"issue":"3","key":"10.1016\/j.asjsur.2022.12.014_bib18","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/neuonc\/noy192","article-title":"Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma","volume":"21","author":"Grommes","year":"2019","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.asjsur.2022.12.014_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0360-3016(92)90538-S","article-title":"Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315","volume":"23","author":"Nelson","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.asjsur.2022.12.014_bib20","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0360-3016(95)00207-F","article-title":"Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy?","volume":"33","author":"O'Neill","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.asjsur.2022.12.014_bib21","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1200\/JCO.1996.14.2.556","article-title":"Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06","volume":"14","author":"Schultz","year":"1996","journal-title":"J\u00a0Clin Oncol: official journal of the American Society of Clinical Oncology. Feb"},{"issue":"6","key":"10.1016\/j.asjsur.2022.12.014_bib22","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/1097-0142(20000915)89:6<1359::AID-CNCR21>3.0.CO;2-9","article-title":"A\u00a0medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma: cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy","volume":"89","author":"Mead","year":"2000","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.asjsur.2022.12.014_bib23","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1200\/JCO.1992.10.4.635","article-title":"Combined modality therapy for primary CNS lymphoma","volume":"10","author":"DeAngelis","year":"1992","journal-title":"J\u00a0Clin Oncol: official journal of the American Society of Clinical Oncology"},{"issue":"24","key":"10.1016\/j.asjsur.2022.12.014_bib24","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1200\/JCO.2003.03.108","article-title":"High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962","volume":"21","author":"Poortmans","year":"2003","journal-title":"J\u00a0Clin Oncol : official journal of the American Society of Clinical Oncology"}],"container-title":["Asian Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1015958422017225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1015958422017225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T17:29:53Z","timestamp":1760894993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1015958422017225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1015958422017225"],"URL":"https:\/\/doi.org\/10.1016\/j.asjsur.2022.12.014","relation":{},"ISSN":["1015-9584"],"issn-type":[{"type":"print","value":"1015-9584"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic factors for primary diffuse large B-cell lymphoma of the brain","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.asjsur.2022.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Asian Surgical Association and Taiwan Robotic Surgery Association. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}